FLOXAPEN

This brand name is authorized in Austria, Estonia, Ireland, Malta, Netherlands.

Active ingredients

The drug FLOXAPEN contains one active pharmaceutical ingredient (API):

1	Floxacillin UNII LMG7C674WJ - FLUCLOXACILLIN SODIUM MONOHYDRATE
	Flucloxacillin is an isoxazolyl penicillin of the β-lactam group of antibiotics which exerts a bactericidal effect upon many Gram-positive organisms including β-lactamase-producing staphylococci and streptococci.
	Read more about Floxacillin

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
FLOXAPEN Powder for solution for injection / infusion	MPI, EU: SmPC	Health Products Regulatory Authority (IE)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01CF05	Flucloxacillin	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01C Beta-lactam antibacterials, penicillins → J01CF Beta-lactamase resistant penicillins
Discover more medicines within J01CF05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
EE	Ravimiamet	1801112, 1822980
IE	Health Products Regulatory Authority	24152, 78479, 78484, 78492
MT	Medicines Authority	AA565/85001, AA565/85002, AA565/85004
NL	Z-Index G-Standaard, PRK	5282, 5290, 5304, 76325